178 related articles for article (PubMed ID: 21972248)
41. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma.
Landen JW; Lang R; McMahon SJ; Rusan NM; Yvon AM; Adams AW; Sorcinelli MD; Campbell R; Bonaccorsi P; Ansel JC; Archer DR; Wadsworth P; Armstrong CA; Joshi HC
Cancer Res; 2002 Jul; 62(14):4109-14. PubMed ID: 12124349
[TBL] [Abstract][Full Text] [Related]
42. Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents-synthesis, antiproliferative activity and inhibition of tubulin polymerization.
Prinz H; Schmidt P; Böhm KJ; Baasner S; Müller K; Gerlach M; Günther EG; Unger E
Bioorg Med Chem; 2011 Jul; 19(14):4183-91. PubMed ID: 21705223
[TBL] [Abstract][Full Text] [Related]
43. Induction of acetylation and bundling of cellular microtubules by 9-(4-vinylphenyl) noscapine elicits S-phase arrest in MDA-MB-231 cells.
Cheriyamundath S; Mahaddalkar T; Kantevari S; Lopus M
Biomed Pharmacother; 2017 Feb; 86():74-80. PubMed ID: 27939522
[TBL] [Abstract][Full Text] [Related]
44. Copper(I) mediated facile synthesis of potent tubulin polymerization inhibitor, 9-amino-α-noscapine from natural α-noscapine.
Manchukonda NK; Sridhar B; Naik PK; Joshi HC; Kantevari S
Bioorg Med Chem Lett; 2012 Apr; 22(8):2983-7. PubMed ID: 22425569
[TBL] [Abstract][Full Text] [Related]
45. Stochastic entropy QSAR for the in silico discovery of anticancer compounds: prediction, synthesis, and in vitro assay of new purine carbanucleosides.
González-Díaz H; Viña D; Santana L; de Clercq E; Uriarte E
Bioorg Med Chem; 2006 Feb; 14(4):1095-107. PubMed ID: 16253507
[TBL] [Abstract][Full Text] [Related]
46. Molecular modeling reveals binding interface of γ-tubulin with GCP4 and interactions with noscapinoids.
Suri C; Joshi HC; Naik PK
Proteins; 2015 May; 83(5):827-43. PubMed ID: 25662919
[TBL] [Abstract][Full Text] [Related]
47. 3D-QSAR CoMFA studies on bis-coumarine analogues as urease inhibitors: a strategic design in anti-urease agents.
Zaheer-ul-Haq ; Lodhi MA; Ahmad Nawaz S; Iqbal S; Mohammed Khan K; Rode BM; Atta-ur-Rahman ; Choudhary MI
Bioorg Med Chem; 2008 Mar; 16(6):3456-61. PubMed ID: 18280742
[TBL] [Abstract][Full Text] [Related]
48. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
Hansch C; Verma RP
Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
[TBL] [Abstract][Full Text] [Related]
49. Development of predictive quantitative structure-activity relationship models of epipodophyllotoxin derivatives.
Naik PK; Dubey A; Kumar R
J Biomol Screen; 2010 Dec; 15(10):1194-203. PubMed ID: 20926843
[TBL] [Abstract][Full Text] [Related]
50. NMR QSAR model for the analysis of 4-(5-arylamino-1,3,4-thiadiazol-2-yl)benzene-1,3-diols.
Matysiak J; Niewiadomy A; Paw B; Dybała I
Arch Pharm (Weinheim); 2011 May; 344(5):340-4. PubMed ID: 21290429
[TBL] [Abstract][Full Text] [Related]
51. Binding orientations, QSAR, and molecular design of thiophene derivative inhibitors.
Liao SY; Chen TJ; Miao TF; Qian L; Zheng KC
Chem Biol Drug Des; 2009 Sep; 74(3):289-96. PubMed ID: 19703031
[TBL] [Abstract][Full Text] [Related]
52. Optimization of antisense drug design against conservative local motif in simulant secondary structures of HER-2 mRNA and QSAR analysis.
Yang SP; Song ST; Tang ZM; Song HF
Acta Pharmacol Sin; 2003 Sep; 24(9):897-902. PubMed ID: 12956938
[TBL] [Abstract][Full Text] [Related]
53. Antiproliferative Noscapinoids Bearing an Amidothiadiazole Scaffold as Apoptosis Inducers: Design, Synthesis and Molecular Docking.
Kumar Pedapati R; Pragyandipta P; Pranathi Abburi N; Chirra N; Kantevari S; Naik PK
Chem Biodivers; 2023 Feb; 20(2):e202201089. PubMed ID: 36690497
[TBL] [Abstract][Full Text] [Related]
54. 2D- and 3D-QSAR studies on 54 anti-tumor Rubiaceae-type cyclopeptides.
Yan H; Pan X; Tan N; Fan J; Zeng G; Han H
Eur J Med Chem; 2009 Sep; 44(9):3425-32. PubMed ID: 19303172
[TBL] [Abstract][Full Text] [Related]
55. The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents.
Debono AJ; Mistry SJ; Xie J; Muthiah D; Phillips J; Ventura S; Callaghan R; Pouton CW; Capuano B; Scammells PJ
ChemMedChem; 2014 Feb; 9(2):399-410. PubMed ID: 24339417
[TBL] [Abstract][Full Text] [Related]
56. Molecular modelling and competition binding study of Br-noscapine and colchicine provide insight into noscapinoid-tubulin binding site.
Naik PK; Santoshi S; Rai A; Joshi HC
J Mol Graph Model; 2011 Jun; 29(7):947-55. PubMed ID: 21530342
[TBL] [Abstract][Full Text] [Related]
57. Novel N-(3-carboxyl-9-benzyl-beta-carboline-1-yl)ethylamino acids: synthesis, anti-tumor evaluation, intercalating determination, 3D QSAR analysis and docking investigation.
Wu J; Zhao M; Qian K; Lee KH; Morris-Natschke S; Peng S
Eur J Med Chem; 2009 Oct; 44(10):4153-61. PubMed ID: 19535177
[TBL] [Abstract][Full Text] [Related]
58. CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism.
Yang Y; Ran J; Sun L; Sun X; Luo Y; Yan B; Tala ; Liu M; Li D; Zhang L; Bao G; Zhou J
Theranostics; 2015; 5(7):656-66. PubMed ID: 25897332
[TBL] [Abstract][Full Text] [Related]
59. Substituted quinazolines, part 3. Synthesis, in vitro antitumor activity and molecular modeling study of certain 2-thieno-4(3H)-quinazolinone analogs.
Al-Obaid AM; Abdel-Hamide SG; El-Kashef HA; Abdel-Aziz AA; El-Azab AS; Al-Khamees HA; El-Subbagh HI
Eur J Med Chem; 2009 Jun; 44(6):2379-91. PubMed ID: 18950904
[TBL] [Abstract][Full Text] [Related]
60. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
